Neurology40-Hz Light-and-Sound Therapy for Alzheimer’s Falters in Phase 3 Trial, Raising Questions Over Subgroup Signal and TranslationCognito’s Spectris AD missed primary endpoints in its pivotal trial, but saw better outcomes for...Nov 19, 2026